Literature DB >> 3974246

High incidence of liver metastasis in gastric cancer with medullary growth pattern.

N Kaibara, O Kimura, H Nishidoi, M Makino, H Kawasumi, S Koga.   

Abstract

We studied the histology of resected specimens from 71 gastric cancer patients with synchronous and metachronous liver metastasis to assess the predominance of a particular histological pattern in gastric cancer with a tendency for liver metastasis. Poorly differentiated adenocarcinoma manifesting a medullary growth pattern was the most frequent histologic pattern (33%), followed by papillary adenocarcinoma (28%) in 39 patients with synchronous liver metastasis. In 32 patients who developed metachronous liver metastasis as the main pattern of recurrence, papillary adenocarcinoma was most frequent (47%), followed by poorly differentiated adenocarcinoma of the medullary type (28%). Scirrhous carcinoma was not encountered in patients manifesting metachronous liver metastasis. As most of the papillary adenocarcinomas exhibited a medullary growth pattern, we hypothesize that gastric cancer of the medullary type tends to metastasize to the liver, irrespective of the basic histologic pattern, and that poorly differentiated adenocarcinoma of the medullary type has a particularly high tendency for metastasizing to the liver.

Entities:  

Mesh:

Year:  1985        PMID: 3974246     DOI: 10.1002/jso.2930280310

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  16 in total

1.  Clinicopathological study of brain metastasis in gastric cancer patients.

Authors:  Y Kasakura; M Fujii; F Mochizuki; T Suzuki; T Takahashi
Journal:  Surg Today       Date:  2000       Impact factor: 2.549

2.  Resected acinar cell carcinoma of the pancreas with tumor thrombus extending into the main portal vein: report of a case.

Authors:  T Ueda; Y Ku; T Kanamaru; Y Hasegawa; Y Kuroda; Y Saitoh
Journal:  Surg Today       Date:  1996       Impact factor: 2.549

3.  Clinicopathologic and prognostic characterization of poorly differentiated medullary-type gastric adenocarcinoma.

Authors:  Eigo Otsuji; Yoshiaki Kuriu; Daisuke Ichikawa; Toshiya Ochiai; Kazuma Okamoto; Akeo Hagiwara; Hisakazu Yamagishi
Journal:  World J Surg       Date:  2004-09       Impact factor: 3.352

4.  Establishment and characterization of three novel human gastric cancer cell lines with differentiated intestinal phenotype derived from liver metastasis.

Authors:  Hayao Nakanishi; Kenzo Yasui; Yuzuru Ikehara; Hiroyuki Yokoyama; Seiichi Munesue; Yasuhiro Kodera; Masae Tatematsu
Journal:  Clin Exp Metastasis       Date:  2005       Impact factor: 5.150

5.  Angiogenesis in poorly differentiated medullary carcinoma of the stomach.

Authors:  Y Takahashi; L M Ellis; T Ohta; M Mai
Journal:  Surg Today       Date:  1998       Impact factor: 2.549

6.  Close association between tumour cells and vascular basement membrane in gastric cancers with liver metastasis. An immunohistochemical and electron microscopic study with special attention to extracellular matrices.

Authors:  H Nakanishi; M Okayama; K Oguri; K Hayashi; H Tateno; S Hosoda
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1991

7.  Frequent microsatellite instability in papillary and solid-type, poorly differentiated adenocarcinomas of the stomach.

Authors:  Tomio Arai; Urara Sakurai; Motoji Sawabe; Naoko Honma; Junko Aida; Yasuko Ushio; Nobuo Kanazawa; Kojiro Kuroiwa; Kaiyo Takubo
Journal:  Gastric Cancer       Date:  2012-12-29       Impact factor: 7.370

8.  Clinical and prognostic characteristics of papillary clear carcinoma of stomach.

Authors:  K Uefuji; T Ichikura; S Tamakuma
Journal:  Surg Today       Date:  1996       Impact factor: 2.549

9.  Early gastric cancer associated with synchronous liver metastasis and portal tumorous embolism: report of a case.

Authors:  Y Nakata; Y Watanabe; T Nakata; K Kimura; M Sato; K Kawachi
Journal:  Surg Today       Date:  1998       Impact factor: 2.549

10.  Metastatic mode and DNA ploidy in gastric carcinoma.

Authors:  Y Umehara; T Kimura; M Yoshida; N Oba; Y Harada
Journal:  Surg Today       Date:  1992       Impact factor: 2.549

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.